Exogenous human herpesvirus 6 reinfection after tumor-infiltrating T-lymphocyte therapy - Archive ouverte HAL Access content directly
Journal Articles Cytotherapy Year : 2018

Exogenous human herpesvirus 6 reinfection after tumor-infiltrating T-lymphocyte therapy

(1, 2) , (1, 3) , (1, 4) , (1, 4) , (5) , (1, 3) , (1, 3) , (6, 7, 8) , (2) , (1, 4) , (1, 4)
1
2
3
4
5
6
7
8

Abstract

Exogenous human herpes virus 6 (HHV-6) reinfection has never been reported in patients receiving tumor-infiltrating T lymphocytes therapy. We report an unusual case of HHV-6 infection following infusion of HHV-6 infected autologous T lymphocytes. HHV-6 infection could interfere with the tumor antigen immune recognition and the efficacy of immunotherapy.
Not file

Dates and versions

hal-02059880 , version 1 (07-03-2019)

Identifiers

Cite

Anastasiia Filippova, Julie Charles, Olivier Epaulard, Raphaële Germi, Virginie Persoons, et al.. Exogenous human herpesvirus 6 reinfection after tumor-infiltrating T-lymphocyte therapy. Cytotherapy, 2018, 20 (4), pp.521-523. ⟨10.1016/j.jcyt.2017.12.006⟩. ⟨hal-02059880⟩
51 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More